2026-07-21T14:00:50Zhttps://repisalud.isciii.es/rest/oai/requestoai:repisalud.isciii.es:20.500.12105/225662024-11-29T05:41:02Zcom_20.500.12105_15322com_20.500.12105_2051col_20.500.12105_16967
Repisalud
author
Rubiño Díaz, Jose Ángel
author
Andres, Pilar
2024-09-06T09:55:57Z
2024-09-06T09:55:57Z
2018-08-14
Rubino J, Andres P. The Face-Name Associative Memory Test as a Tool for Early Diagnosis of Alzheimer's Disease. Front Psychol. 2018 Aug 14;9:1464.
10.3389/fpsyg.2018.01464
1664-1078
Frontiers in Psychology
http://hdl.handle.net/20.500.13003/9172
30154753
2-s2.0-85051476777
https://hdl.handle.net/20.500.12105/22566
441700600001
One current challenge for neuropsychologists is to design assessment methods capable of detecting cognitive deficits in the early or preclinical phases of Alzheimer's disease (AD). The objective of this paper is to review the studies that have explored the use of the Face-Name Associative Memory Exam (FNAME) as a test for early diagnosis of AD. Studies looking at correlations between performance on the FNAME test and biomarkers in healthy people and studies comparing healthy controls and people with mild cognitive impairment are reviewed. These studies are based on the evidence that AD's pathological process begins years before the most visible clinical manifestations. We conclude that the FNAME test may be a valuable tool for early diagnosis but that some important questions remain to be resolved in future research.
eng
Alzheimer's disease
Early diagnosis
Mild cognitive impairment
Neuropsychological evaluation
FNAME
Associative memory
The Face-Name Associative Memory Test as a Tool for Early Diagnosis of Alzheimer's Disease
review article